PALISADE CAPITAL MANAGEMENT, LP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 16 filers reported holding PTC THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,681,000
-65.4%
1,672,000
-64.2%
0.05%
-58.9%
Q1 2022$4,858,000
-2.1%
4,672,0000.0%0.11%
+10.9%
Q4 2021$4,964,000
+12.0%
4,672,000
+9.8%
0.10%
+4.1%
Q3 2021$4,432,000
+224.2%
4,254,000
+239.2%
0.10%
+212.9%
Q2 2021$1,367,000
-47.3%
1,254,000
-44.4%
0.03%
-49.2%
Q1 2021$2,595,000
-10.5%
2,254,0000.0%0.06%
-17.6%
Q4 2020$2,901,000
+12.9%
2,254,0000.0%0.07%
-2.6%
Q3 2020$2,570,000
-3.1%
2,254,0000.0%0.08%
-9.5%
Q2 2020$2,653,000
+3.3%
2,254,000
-2.0%
0.08%
-7.7%
Q1 2020$2,569,000
-2.9%
2,300,0000.0%0.09%
+21.3%
Q4 2019$2,645,000
+11.1%
2,300,0000.0%0.08%
+2.7%
Q3 2019$2,381,0002,300,0000.07%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 31,204,000$33,828,0001.01%
Opti Capital Management, LP 8,000,000$8,743,0000.94%
TENOR CAPITAL MANAGEMENT Co., L.P. 15,519,000$16,885,0000.37%
CSS LLC/IL 7,007,000$7,544,0000.31%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 14,527,000$15,558,0000.28%
WOLVERINE ASSET MANAGEMENT LLC 19,454,000$20,896,0000.16%
LMR Partners LLP 9,500,000$10,292,0000.16%
Aequim Alternative Investments LP 2,000,000$2,155,0000.09%
Verition Fund Management LLC 8,091,000$8,718,0000.08%
SG Americas Securities, LLC 61,550$6,632,0000.03%
View complete list of PTC THERAPEUTICS INC shareholders